ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,549Medicare Part D Prescriptions Filled, Including Refills

Rank: 244 out of 4623

$1.25M Total Retail Price of All Prescriptions

Rank: 76 out of 4623

946 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 946 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 11,519 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 664 573 1 4
SIMVASTATIN 639 572 2 2
OMEPRAZOLE 363 306 3 7
METFORMIN HCL 342 278 4 6
TRAMADOL HCL 335 286 5 15
LEVOTHYROXINE SODIUM 333 279 6 1
NEXIUM 281 232 7 17
METOPROLOL SUCCINATE 277 267 8 13
DIOVAN 268 235 9 39
FUROSEMIDE 247 219 10 8
NAPROXEN 247 185 10 63
NAMENDA 237 231 12 36
ALENDRONATE SODIUM 227 217 13 22
METOPROLOL TARTRATE 226 199 14 9
ZOLPIDEM TARTRATE 218 195 15 18
AMLODIPINE BESYLATE 208 191 16 5
TRAMADOL HCL-ACETAMINOPHEN 199 169 17 103
TRICOR 191 160 18 88
TAMSULOSIN HCL 185 173 19 29
CIPROFLOXACIN HCL 183 161 20 43
AMOX TR-POTASSIUM CLAVULANATE 167 129 21 117
DIOVAN HCT 163 154 22 67
AZITHROMYCIN 142 108 23 33
IBUPROFEN 140 108 24 65
DONEPEZIL HCL 137 136 25 30
JANUVIA 136 113 26 52
GLIPIZIDE 136 120 26 49
HYDROCODONE BIT-IBUPROFEN 135 124 S3 28 280
MECLIZINE HCL 128 118 29 125
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 108 30 19
GLYBURIDE-METFORMIN HCL 124 113 R 31 56
ATORVASTATIN CALCIUM 118 109 32 12
DICLOFENAC SODIUM 116 100 33 121
CRESTOR 116 96 33 20
HYDROCODONE-ACETAMINOPHEN 113 78 S3 35 3
ISOSORBIDE MONONITRATE ER 112 108 36 60
DICYCLOMINE HCL 99 81 37 238
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 80 37 68
MELOXICAM 98 95 39 27
CLONIDINE HCL 97 84 40 40
CEPHALEXIN 95 80 41 84
LOSARTAN-HYDROCHLOROTHIAZIDE 93 88 42 46
SERTRALINE HCL 91 79 43 26
WARFARIN SODIUM 90 90 44 24
CLOPIDOGREL 88 79 45 31
NYSTATIN-TRIAMCINOLONE 88 75 45 199
POTASSIUM CHLORIDE 85 82 47 14
LANTUS 84 68 48 44
MEGESTROL ACETATE 77 76 R 49 145
LEVOFLOXACIN 73 65 50 81
PLAVIX 73 68 50 45
AMLODIPINE BESYLATE-BENAZEPRIL 73 68 50 55
JANUMET 72 57 53 136
GABAPENTIN 72 54 53 16
ENALAPRIL MALEATE 70 57 55 41
INSULIN SYRINGE 67 60 56 85
DIGOXIN 63 62 57 58
POLYETHYLENE GLYCOL 3350 62 53 58 91
PEN NEEDLE 62 38 58 122
PANTOPRAZOLE SODIUM 59 57 60 35
CARVEDILOL 58 57 61 25
LYRICA 58 42 61 66
HYDROCHLOROTHIAZIDE 53 52 63 10
LOSARTAN POTASSIUM 53 50 63 21
METHOCARBAMOL 52 40 R 65 155
PROMETHAZINE HCL 50 31 R 66 93
CELEBREX 50 32 66 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.